Recent Advances in Thrombosis and Hemostasis—Part X

Sam Schulman

doi:10.1055/s-0044-1786753

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2024; 50(06): 807-808
DOI: 10.1055/s-0044-1786753

Preface

Recent Advances in Thrombosis and Hemostasis—Part X

Authors

Sam Schulman

¹Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada

²Department of Obstetrics and Gynecology and Perinatal Medicine, The First I.M. Sechenov Moscow State Medical University, Moscow, Russia

Abstract

Full Text

References

References
1 El-Sherbini AH, Coroneos S, Zidan A, Othman M. Machine learning as a diagnostic and prognostic tool for predicting thrombosis in cancer patients: a systematic review. Semin Thromb Hemost 2024; 50 (06) 809-816
2 Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008; 111 (10) 4902-4907
3 Aguirre Del-Pino R, Monahan RC, Huizinga TWJ, Eikenboom J, Steup-Beekman GM. Risk factors for antiphospholipid antibodies and antiphospholipid syndrome. Semin Thromb Hemost 2024; 50 (06) 817-828
4 Schulman S, Arnold DM, Bradbury CA. et al; International Society on Thrombosis and Haemostasis. 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19. J Thromb Haemost 2024; 22 (06) 1779-1797
5 Lippi G, Favaloro EJ, Nocini R. Venous thrombosis in airborne viral infections: is coronavirus disease 2019 now any different from influenza?. Semin Thromb Hemost 2024; 50 (06) 829-834
6 Bozzani A, Arici V, Tavazzi G. et al. Trends (2020–2022) toward reduced prevalence of postcoronavirus disease syndrome and improved quality of life for hospitalized coronavirus disease 2019 patients with severe infection and venous thromboembolism. Semin Thromb Hemost 2024; 50 (06) 835-841
7 Boccatonda A, Andreetto L, Vicari S, Campello E, Simioni P, Ageno W. The diagnostic role of lung ultrasound and contrast-enhanced ultrasound in pulmonary embolism. Semin Thromb Hemost 2023; 50 (06) 842-850
8 Bikdeli B, Sadeghipour P, Lou J. et al. Developmental or procedural vena cava interruption and venous thromboembolism: a review. Semin Thromb Hemost 2024; 50 (06) 851-865
9 Spiezia L, Campello E, Tormene D, Simioni P. Venous thromboembolism in children: the rivaroxaban experience. Semin Thromb Hemost 2024; 50 (06) 866-872
10 Kiskaddon AL, Goldenberg NA, Fierstein JL, Miller A, Quintessenza JA, Kartha VM. Dosing, monitoring, blood product utilization, and thromboembolic complications of four-factor prothrombin complex concentrate as part of an institutional protocol in pediatric cardiac surgery: a retrospective cohort study. Semin Thromb Hemost 2023; 50 (06) 873-882
11 Trujillo-Santos J, Demelo-Rodríguez P, de Laguna Taboada AB. et al. Optimizing venous stenting: consensus recommendations for enhanced management of lower extremity deep vein thrombosis. Semin Thromb Hemost 2024; 50 (06) 883-893
12 Pengo V, Bracco A, Denas G, Iliceto S. Coronary thrombosis with distal embolization in a young patient after orthopaedic surgery: an informative case report. Semin Thromb Hemost 2023; 50 (06) 894-896
13 Fan BE, Sum CLL, Leung BPL. et al. VEXAS syndrome and thrombosis: findings of inflammation, hypercoagulability, and endothelial dysfunction. Semin Thromb Hemost 2024; 50 (06) 897-901
14 Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost 2023; 50 (06) 902-915
15 Simmonds MJ, Meiselman HJ, Detterich JA. Commentary: blood rheology and hemodynamics: still illuminating after 20 years. Semin Thromb Hemost 2024; 50 (06) 916-918